Baseline characteristics of admissions for high-flow nasal cannula oxygen therapy
| Total, n=96 (%) | |
| Sex, male (%) | 70 (72.92%) |
| Age, mean (95% CI) | 61.9 (CI 58.3 to 65.4) |
| Admission location, n (%) | |
| Emergency room | 16 (16.7%) |
| Intensive care unit | 27 (28.1%) |
| Other hospital | 4 (4.2%) |
| Recovery unit | 10 (10.4%) |
| Hospital ward | 39 (40.6%) |
| Underlying diagnoses, n (%) | |
| Trauma | 36 (37.5%) |
| Postoperative abdominal surgery | 26 (27.1%) |
| Esophagogastric bypass surgery | 15 (15.6%) |
| Extra-abdominal surgery | 8 (8.3%) |
| Severe necrotizing tissue disease | 3 (3.11%) |
| Exchange bed | 2 (2.1%) |
| Other | 6 (6.3%) |
| Admission duration in hours, mean (BCA 95% CI) | 98.8 (78.9 to 118.7) |
| Comorbidity, n (%) | |
| Cardiovascular | 50 (52.1%) |
| Pulmonary (COPD/asthma) | 8 (8.3%) |
| Pulmonary (other) | 4 (4.2%) |
| SOFA score, mean (BCA 95% CI) | 3.7 (3.3 to 4.1) |
| ASA classification, n (%) | |
| I | 27 (28.1%) |
| II | 30 (31.3%) |
| III | 37 (38.5%) |
| IV | 2 (2.1%) |
This table shows the baseline characteristics of all admissions at the intermediate care unit, which received high-flow nasal cannula oxygen therapy from 15 July 2016 to 16 August 2017.
ASA, American Society of Anesthesiologists; BCA, bootstrapped confidence interval, COPD, chronic obstructive pulmonary disease; SOFA, Sequential Organ Failure Assessment.